Stock Market Today, Feb: ImmunityBio Up on Anktiva EU OK
ImmunityBio sails higher after the EU green lights ANKTIVA for bladder cancer, igniting waves across biotech stocks. ...
Evaluating credit card rewards is crucial for maximizing value. Learn which options provide the best returns for your spending.
28,180 articlesImmunityBio sails higher after the EU green lights ANKTIVA for bladder cancer, igniting waves across biotech stocks. ...
When a heavyweight like SPGI outperforms in a quiet market, it often signals more than a single stock move. This piec...
Investors watched airline stocks rise after a key sustainable fuel deal was announced. This piece breaks down the dri...
As the AI build-out accelerates, Marvell and Micron report results that highlight two distinct routes to profit: cust...
Thai and Taiwanese AI stock funds are gaining traction as Korea’s AI boom extends across Asia. This report examines w...
As AMD prepares to report its second-quarter results, a bullish outlook centered on AI demand could dominate the conv...
Dragonfly Capital closes a $650 million fund to back early-stage crypto ventures as liquidity tightens and token pric...
Pi Network announces a major protocol upgrade and an AI-focused case study, setting the stage for potential moves aro...
Goldman Sachs and MORGAN STANLEY are jockeying for the lead left role in a pair of AI IPOs, a $7 billion opportunity ...
NexaTech Holdings, a $40 billion market-cap company, raised its revenue guidance on stronger-than-expected demand, si...
July 2026 brings a fresh wave of opportunities in semiconductors. This guide reveals five names with durable demand, ...
AI ambitions collide with power limits. This article explains the gigawatt pivot, why it matters for investors, and w...